Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 1;22(6):916.
doi: 10.3390/molecules22060916.

Chemical Methods to Knock Down the Amyloid Proteins

Affiliations
Review

Chemical Methods to Knock Down the Amyloid Proteins

Na Gao et al. Molecules. .

Abstract

Amyloid proteins are closely related with amyloid diseases and do tremendous harm to human health. However, there is still a lack of effective strategies to treat these amyloid diseases, so it is important to develop novel methods. Accelerating the clearance of amyloid proteins is a favorable method for amyloid disease treatment. Recently, chemical methods for protein reduction have been developed and have attracted much attention. In this review, we focus on the latest progress of chemical methods that knock down amyloid proteins, including the proteolysis-targeting chimera (PROTAC) strategy, the "recognition-cleavage" strategy, the chaperone-mediated autophagy (CMA) strategy, the selectively light-activatable organic and inorganic molecules strategy and other chemical strategies.

Keywords: amyloid proteins; chemical methods; degradation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Proteolysis-targeting chimera (PROTAC) strategy degrades the target protein by the ubiquitin-proteasome system (UPS).
Figure 2
Figure 2
(A) Schematic diagram of “recognition-cleavage” strategy; (B) The structure of cyclen chelating Cu(II).
Figure 3
Figure 3
Schematic diagram of the chaperone-mediated autophagy (CMA) strategy.
Figure 4
Figure 4
Schematic diagram of the selectively light-activatable organic and inorganic molecules strategy.

Similar articles

Cited by

References

    1. Kisilevsky R. Biology of disease amyloidosis: A familiar problem in light of current pathogenic developments. Lab Investig. 1983;49:381–390. - PubMed
    1. Rochet J.C., Lansbury P.T. Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 2000;10:60–68. doi: 10.1016/S0959-440X(99)00049-4. - DOI - PubMed
    1. Sipe J.D. Serum amyloid A: From fibril to function. Current status. Amyloid. 2000;7:10–12. doi: 10.3109/13506120009146815. - DOI - PubMed
    1. Qi Q., Zhao T.X., An B.L., Liu X.Y., Zhong C. Self-assembly and morphological characterization of two-component functional amyloid proteins. Chin. Chem. Lett. 2016;12:008. doi: 10.1016/j.cclet.2016.12.008. - DOI
    1. Selkoe D.J. Alzheimer’s disease: Genotypes, phenotype and treatments. Science. 1997;275:630–631. doi: 10.1126/science.275.5300.630. - DOI - PubMed

MeSH terms